Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 050903/0204 | |
| Pages: | 8 |
| | Recorded: | 11/04/2019 | | |
Attorney Dkt #: | 115872-0723, 115872-0752 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
|
Issue Dt:
|
12/24/2019
|
Application #:
|
16079217
|
Filing Dt:
|
08/23/2018
|
Publication #:
|
|
Pub Dt:
|
02/21/2019
| | | | |
Title:
|
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF THYMIDINE KINASE WITH AND WITHOUT THE EXPRESSION OF HUMAN FLT3L OR GM-CSF FOR CANCER IMMUNOTHERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
08/11/2020
|
Application #:
|
16079222
|
Filing Dt:
|
08/23/2018
|
Publication #:
|
|
Pub Dt:
|
02/14/2019
| | | | |
Title:
|
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF AS IMMUNO-THERAPEUTIC AGENTS AGAINST SOLID TUMORS
|
|
Assignee
|
|
|
1275 YORK AVENUE |
NEW YORK, NEW YORK 10065 |
|
Correspondence name and address
|
|
GEORGE GRAY
|
|
3000 K STREET NW, SUITE 600
|
|
FOLEY & LARDNER LLP
|
|
WASHINGTON, DC 20007
|
Search Results as of:
05/21/2024 12:21 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|